By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc. (CDT)

NASDAQ Currency in USD
$0.60
-$0.01
-1.48%
Last Update: 11 Sept 2025, 20:00
$1.83M
Market Cap
0.11
P/E Ratio (TTM)
Forward Dividend Yield
$0.57 - $274.50
52 Week Range

CDT Stock Price Chart

Explore Conduit Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze CDT price movements and trends.

CDT Company Profile

Discover essential business fundamentals and corporate details for Conduit Pharmaceuticals Inc. (CDT) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

28 Mar 2022

Employees

6.00

CEO

Andrew Regan

Description

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

CDT Financial Timeline

Browse a chronological timeline of Conduit Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 Nov 2025

Earnings released on 14 Aug 2025

EPS came in at -$5.46 .

Stock split effective on 20 May 2025

Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 15 May 2025

EPS came in at -$19.79 .

Earnings released on 28 Mar 2025

EPS came in at -$20.33 , while revenue for the quarter reached $660.74M .

Stock split effective on 27 Jan 2025

Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 14 Nov 2024

EPS came in at -$7.00 , while revenue for the quarter reached $244.00M .

Earnings released on 12 Aug 2024

EPS came in at -$7.00 , while revenue for the quarter reached $604.34M .

Earnings released on 14 May 2024

EPS came in at -$0.05 , while revenue for the quarter reached $535.68M .

Earnings released on 25 Mar 2024

EPS came in at $0.04 .

Earnings released on 20 Nov 2023

EPS came in at -$0.80 .

Earnings released on 30 Sept 2023

EPS came in at $0.06 .

Earnings released on 31 Mar 2023

EPS came in at -$1.17 .

Earnings released on 31 Dec 2022

EPS came in at -$0.36 .

Earnings released on 30 Sept 2022

EPS came in at -$0.03 .

Earnings released on 29 Jun 2022

EPS came in at -$0.01 .

Earnings released on 31 Mar 2022

EPS came in at -$0.01 .

Earnings released on 30 Dec 2021

EPS came in at -$0.00 .

CDT Stock Performance

Access detailed CDT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run